يعرض 1 - 10 نتائج من 31 نتيجة بحث عن '"Wolfgang Dummer"', وقت الاستعلام: 1.23s تنقيح النتائج
  1. 1
    دورية أكاديمية
    PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS

    المؤلفون: Guillermo Garcia-Manero, Lewis Silverman, Lucy Yan, Wolfgang Dummer

    المصدر: HemaSphere, Vol 7, p e9155290 (2023)

    مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

    وصف الملف: electronic resource

    Relation: http://journals.lww.com/10.1097/01.HS9.0000974884.91552.90; https://doaj.org/toc/2572-9241

    URL الوصول: https://doaj.org/article/d0013abee4ee441ab4e66a8ce60bf27a

    View record in Lippincott, Williams & Wilkins View record at Wiley Full Text Finder
    أضف إلى المفضلة
  2. 2
    1141. Phase 3 Trial (in progress) of the SYK Inhibitor Fostamatinib in Patients Hospitalized with COVID-19: Protocol and Study Implementation Updates

    المؤلفون: Lucy Yan, Ziad Mallat, Suzana Margareth Lobo, Anuj Malik, Wolfgang Dummer

    المصدر: Open Forum Infectious Diseases. 9

    مصطلحات موضوعية: Infectious Diseases, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e98a9c6289402ba21b363425149fb52b
    https://doi.org/10.1093/ofid/ofac492.979

    أضف إلى المفضلة
  3. 3
    Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study (FORWARD) of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

    المؤلفون: David J. Kuter, Caroline I. Piatek, Khalil Saikali, Wolfgang Dummer

    المصدر: Blood. 140:2438-2439

    مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c4c43bb806bec3c5ca86b7633b66077a
    https://doi.org/10.1182/blood-2022-169652

    أضف إلى المفضلة
  4. 4
    674. Pre-Clinical and Phase I Safety Data for Anti-Pseudomonas aeruginosa Human Monoclonal Antibody AR-105

    المؤلفون: Andreas Loos, Nadine Weich, Jennifer S. Woo, Guy Lalonde, Luisa Yee, Vu L. Truong, Wolfgang Dummer

    المصدر: Open Forum Infectious Diseases

    مصطلحات موضوعية: 0301 basic medicine, medicine.drug_class, Pseudomonas aeruginosa, business.industry, Immunogenicity, 030106 microbiology, Antibiotics, Phases of clinical research, Monoclonal antibody, medicine.disease_cause, Epitope, In vitro, Abstracts, 03 medical and health sciences, 0302 clinical medicine, Infectious Diseases, Oncology, Poster Abstracts, Immunology, Adjunctive treatment, medicine, 030212 general & internal medicine, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da6cec849377b89161bfcc247fe36eb
    https://doi.org/10.1093/ofid/ofz360.742

    أضف إلى المفضلة
  5. 5
    Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications

    المؤلفون: Vadim Markovtsov, Sandra Tong, Esteban Masuda, Wolfgang Dummer

    المصدر: Blood

    مصطلحات موضوعية: ARDS, business.industry, Immunology, Acute kidney injury, Syk, Cell Biology, Hematology, Lung injury, medicine.disease, Fostamatinib, Biochemistry, Immune system, Rheumatoid arthritis, medicine, 331.Pathophysiology of Thrombosis, Cytokine storm, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dbaebe9aca8034b37ec8710429a8db6
    https://doi.org/10.1182/blood-2020-141045

    أضف إلى المفضلة
  6. 6
    Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

    المؤلفون: Strive Investigators, Wolfgang Dummer, Simon Jones, Roberto Giugliani, Maurizio Scarpa, Vassili Valayannopoulos, Shuan-Pei Lin, Paul Harmatz, Debra L. Lounsbury, Barbara K. Burton, Peter Slasor, Thomas R. Fleming, Derralynn Hughes, Eugen Mengel, Christian J. Hendriksz

    المصدر: STRIVE Investigators 2014, ' Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA) : A phase 3 randomised placebo-controlled study ', Journal of Inherited Metabolic Disease, vol. 37, no. 6, pp. 979-990 . https://doi.org/10.1007/s10545-014-9715-6
    Journal of Inherited Metabolic Disease

    مصطلحات موضوعية: Adult, Male, congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, Morquio syndrome, Adolescent, Placebo-controlled study, Walking, Motor Activity, Placebo, law.invention, Efficacy, Young Adult, chemistry.chemical_compound, Rare Diseases, Double-Blind Method, Randomized controlled trial, Elosulfase alfa, law, Internal medicine, Genetics, medicine, Humans, Enzyme Replacement Therapy, Genetics(clinical), Respiratory function, Child, Genetics (clinical), business.industry, fungi, Mucopolysaccharidosis IV, virus diseases, nutritional and metabolic diseases, Middle Aged, medicine.disease, Chondroitinsulfatases, 3. Good health, Discontinuation, Treatment Outcome, chemistry, Keratan Sulfate, Child, Preschool, Original Article, Female, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce90913ba268a2a462fbbf7743596e0
    https://doi.org/10.1007/s10545-014-9715-6

    Find this article in full text from Springer Verlag. View record at Wiley Find this article in full text from ProQuest
    أضف إلى المفضلة
  7. 7
    Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial

    المؤلفون: Mark C. Genovese, Yoshiya Tanaka, Philip J. Mease, Boulos Haraoui, Joel M. Kremer, P. P. Tak, Clifton O. Bingham, S. Safa-Leathers, S. Kumar, A. Ashrafzadeh, Wolfgang Dummer, Helen Travers

    المساهمون: Clinical Immunology and Rheumatology

    المصدر: Arthritis and rheumatism, 64(2), 360-370. John Wiley and Sons Inc.

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Immunology, Arthritis, Antibodies, Monoclonal, Humanized, Placebo, Gastroenterology, law.invention, Arthritis, Rheumatoid, Double-Blind Method, Rheumatology, Randomized controlled trial, law, Internal medicine, medicine, Humans, Immunology and Allergy, Pharmacology (medical), Adverse effect, Aged, Leflunomide, Tumor Necrosis Factor-alpha, business.industry, Middle Aged, medicine.disease, Surgery, Clinical trial, Treatment Outcome, Antirheumatic Agents, Rheumatoid arthritis, Female, Ocrelizumab, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d1d9e1b62a3c22833a648b4ced25ce1
    https://doi.org/10.1002/art.33353

    View record at Wiley
    أضف إلى المفضلة
  8. 8
    Single- versus dual-infusion of B-cell-depleting antibody ocrelizumab in rheumatoid arthritis: results from the Phase III FEATURE trial

    المؤلفون: Farhad Sedarati, Wolfgang Dummer, Piotr Leszczyński, James Taylor, Joseph E Huffstutter, Dalia Moawad, Joy Schechtman, Marek Brzosko, Amy V Kapp, Rebecca Sudlow

    المصدر: International Journal of Clinical Rheumatology. 6:689-696

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, medicine.disease, Placebo, Gastroenterology, Rheumatology, Surgery, Therapeutic index, Pharmacokinetics, Rheumatoid arthritis, Internal medicine, medicine, Clinical endpoint, Ocrelizumab, business, Adverse effect, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::680acae38378ff4f2ca3141bbe0ce324
    https://doi.org/10.2217/ijr.11.55

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  9. 9
    Effect of Therapeutic Integrin (CD11a) Blockade with Efalizumab on Immune Responses to Model Antigens in Humans: Results of a Randomized, Single Blind Study

    المؤلفون: James G. Krueger, Hans D. Ochs, Piyush M. Patel, Wolfgang Dummer, Ellen Gilkerson, Emma Guttman-Yassky

    المصدر: Journal of Investigative Dermatology. 128(11):2615-2624

    مصطلحات موضوعية: Adult, Male, T-Lymphocytes, Efalizumab, CD11a, Dermatology, Antibodies, Monoclonal, Humanized, Biochemistry, Pneumococcal Vaccines, Immune system, Antigen, Tetanus Toxoid, medicine, Humans, Psoriasis, Single-Blind Method, CD11a Antigen, Molecular Biology, Aged, Skin Tests, Antigens, Bacterial, B-Lymphocytes, biology, business.industry, Antibody titer, Antibodies, Monoclonal, Cell Biology, Middle Aged, Antibodies, Bacterial, Vaccination, Immunoglobulin M, Immunoglobulin G, Antibody Formation, Immunology, Humoral immunity, biology.protein, Female, Antibody, business, Bacteriophage phi X 174, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b37536683cde84053ac715c442e046d

    View record from ScienceDirect Find this article in full text from ProQuest
    أضف إلى المفضلة
  10. 10
    Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study

    المؤلفون: Mark C, Genovese, Jeffrey L, Kaine, Mitchell B, Lowenstein, José, Del Giudice, Andrew, Baldassare, Joy, Schechtman, Edward, Fudman, Michael, Kohen, Sheila, Gujrathi, Robert G, Trapp, Nadera J, Sweiss, Greg, Spaniolo, Wolfgang, Dummer, S, Wolfe

    المصدر: Arthritis & Rheumatism. 58:2652-2661

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Immunology, Population, Antibodies, Monoclonal, Humanized, Placebo, Severity of Illness Index, Gastroenterology, Drug Administration Schedule, Arthritis, Rheumatoid, Double-Blind Method, Rheumatology, Internal medicine, medicine, Humans, Immunologic Factors, Immunology and Allergy, Rheumatoid factor, Pharmacology (medical), education, Adverse effect, Aged, Aged, 80 and over, B-Lymphocytes, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Patient Selection, Remission Induction, Antibodies, Monoclonal, Middle Aged, medicine.disease, Dose-ranging study, Intention to Treat Analysis, Surgery, C-Reactive Protein, Methotrexate, Treatment Outcome, Immunoglobulin M, Antirheumatic Agents, Rheumatoid arthritis, Pharmacodynamics, Drug Therapy, Combination, Female, Ocrelizumab, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::506077b8847251fb8b25c62aa3a42679
    https://doi.org/10.1002/art.23732

    View record at Wiley
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء